Search results

29 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Carey to co-chair national breast cancer clinical trials group
UNC Lineberger member Lisa A. Carey, MD, has been appointed co-chair of the Alliance for Clinical Trials in Oncology Breast Committee. The national organization is responsible for developing new trials, ensuring each project’s scientific excellence, operational efficiency and productivity, and promoting collaboration with other NCI-funded clinical trials groups.
Located in News
Menopausal status may be more important than age in breast cancer screening frequency, study finds
A study published in JAMA Oncology found that pre-menopausal women who were diagnosed with breast cancer following a biennial screening mammogram were likely to have more advanced tumors than woman screened annually. UNC Lineberger researcher Louise Henderson was a co-author on the study, which was co-led by researchers at the University of California-Davis School of Medicine and the Dana-Farber Cancer Institute.
Located in Newsletters / / Honors and Awards / 2015
Assessment is first to measure breast and cervical cancer landscape in Zambia
The assessment, co-published by UNC Lineberger member and professor of gynecologic oncology Groesbeck Parham, MD, not only identifies the roadblocks to treatment, but also provides a path to overcoming them.
Located in News
Located in Newsroom
Researchers explore roots of breast cancer disparities at symposium
A symposium co-sponsored by the UNC Lineberger Comprehensive Cancer Center brought leading breast cancer researchers together Friday to share findings about the genetic and environmental factors driving disparities in the disease’s incidence and mortality.
Located in News
Eligible for breast conserving therapy, many still choose mastectomy
New treatment strategies have given more triple-negative breast cancer patients the choice of breast-conserving surgery. But research led by Brigham and Women's Hospital, in collaboration with UNC Lineberger member David Ollila, MD, has shown that even when given the choice, more than 30 percent of patients still chose to have a complete breast removal via mastectomy.
Located in News
Early menarche may be important in development of aggressive breast cancer in African-American women
A multicenter research team known as the African American Breast Cancer Epidemiology and Risk Consortium (AMBER), which includes UNC Lineberger's Andrew Olshan, PhD has uncovered differences in ER-positive & ER-negative breast cancer pathways. The team examined whether relationships between age at menarche and breast cancer are the same for tumors that are ER-positive or ER-negative, particularly among African-American women. ER-negative breast cancer is generally more aggressive and known to be associated with a poorer prognosis than ER-positive disease.
Located in News
Rock stars for a day
As a breast cancer survivor, Barbara Martin has established a tradition – walking 39 miles to raise awareness and funds for breast cancer – that has become very special to her. This challenge became even more special this year, as her mother and daughter were both by her side along the way.
Located in News
UNC Lineberger-led study tests drug strategy for aggressive breast cancer in the brain
Results from a UNC Lineberger-led study were published Monday in the journal Molecular Cancer Therapeutics. The pre-clinical study was the first to investigate one particular drug strategy as a treatment for breast cancer after it's spread to the brain.
Located in News
Who says you can’t go home?
Amy Charney had already registered to run the 2015 Boston Marathon when she was told she had breast cancer. But not even that diagnosis and active treatment would keep her from crossing the finish line in her hometown of Boston.
Located in News